Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509283 · ClinicalTrials.gov registry record · NA
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40,671
- Enrollment target
NCT05509283: Completed NA study, sponsored by Geisinger Clinic.
NCT05509283 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 40,671 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2799% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05509283, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40,671 participants
- Enrollment target
Study Summary
This study will test the relative efficacy of high-risk messages in increasing flu shot rates in patients at moderately high risk for flu and complications (those in the top 11-20% of risk). It will also examine whether informing patients that their high-risk status was determined by analyzing their medical records or by an artificial intelligence (AI) / machine-learning (ML) algorithm analyzing their medical records will affect the likelihood of receiving a flu vaccine.
Primary Outcome
Received a flu vaccination within within 6 weeks of the patient's study start date
Interventions
- BEHAVIORAL Risk Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,671 participants |
| Start Date | 2022-09-13 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
What the finished NCT05509283 record still lists
NCT05509283 is an interventional study that assigns participants to a tested intervention. Its 40,671 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2799% higher).
The record links to 0 conditions, and to 1 intervention - of which Risk Reduction is the first listed.
NCT05509283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05509283 about?
NCT05509283 is a clinical study titled "Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications". This study will test the relative efficacy of high-risk messages in increasing flu shot rates in patients at moderately high risk for flu and complications (those in the top 11-20% of risk). It will also examine whether informing patients that their high-risk status was determined by analyzing their...
What is the current status of trial NCT05509283?
This trial is currently completed. It is a NA study. The enrollment target is 40,671 participants. The study started on 2022-09-13. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05509283?
The interventions under investigation include: Risk Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05509283?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05509283's enrollment target sits among peer trials
40,671 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI